Valeant Providing Reporters With an Earnings Metric the SEC Ordered it to Stop Using Post author:Sam Post published:November 9, 2017 Post category:BioPharma Valeant is not the only company to recently push reporters to defy the SEC’s orders. Source: BioSpace You Might Also Like Afraxis, Inc. Announces New Imagedirect (SM) Analysis Service March 9, 2017 XBiotech Announces Additions To Its Scientific Advisory Board April 9, 2017 3 Key Reasons Why a Gilead-Vertex Marriage May Not be a Match Made in Biotech Heaven July 4, 2017
